Tenax Therapeutics Inc TENX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
4.02quote price arrow down-0.22 (-5.19%)
Volume
2,227
Close
4.24UNCH (UNCH)
Volume
204,360
52 week range
3.48 - 61.20
Loading...
  • Open3.94
  • Day High4.25
  • Day Low3.86
  • Prev Close3.87
  • 52 Week High61.20
  • 52 Week High Date11/14/23
  • 52 Week Low3.48
  • 52 Week Low Date03/26/24

Key Stats

  • Market Cap7.488M
  • Shares Out1.77M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.23
  • YTD % Change-80.7

KEY STATS

  • Open3.94
  • Day High4.25
  • Day Low3.86
  • Prev Close3.87
  • 52 Week High61.20
  • 52 Week High Date11/14/23
  • 52 Week Low3.48
  • 52 Week Low Date03/26/24
  • Market Cap7.488M
  • Shares Out1.77M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.23
  • YTD % Change-80.7

RATIOS/PROFITABILITY

  • EPS (TTM)-122.31
  • P/E (TTM)-0.03
  • Fwd P/E (NTM)-0.34
  • EBITDA (TTM)-7.443M
  • ROE (TTM)-92.30%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)1.55%

EVENTS

  • Earnings Date03/28/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tenax Therapeutics Inc

 

Profile

MORE
Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The Company's products include TNX-201 (oral enteric coated imatinib) and TNX-103 (oral levosimendan). The Company is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH)....
Gerald Proehl
Independent Chairman of the Board
Christopher Giordano
President, Chief Executive Officer, Director
Lawrence Hoffman
Interim Chief Financial Officer
Address
101 GLEN LENNOX DRIVE, SUITE 300
Chapel Hill, NC
27517
United States

Top Peers

SYMBOLLASTCHG%CHG
HOTH
Hoth Therapeutics Inc
1.52UNCHUNCH
ATXI
Avenue Therapeutics Inc
0.1475UNCHUNCH
CING
Cingulate Inc
1.10UNCHUNCH
AKTX
Akari Therapeutics PLC
1.85UNCHUNCH
OGEN
Oragenics Inc
1.44UNCHUNCH